关于托珠单抗 用于危重新冠病人 “Roche has announced that the US Food and Drug Administration (FDA) has formally approved its phase 3 trial of Actemra in severely ill COVID-19 patients, who have been hospitalised with pneumonia. ”
[url=https://www.pmlive.com/pharma_news/fda_approves_roches_actemra_covid-19_trial_1329887]https://www.pmlive.com/pharma_news/fda_approves_roches_actemra_covid-19_trial_1329887[/url]
我不是学医的,bless lz和你的朋友一家